BLOOD LIPID CONCENTRATIONS AND OTHER CARDIOVASCULAR RISK-FACTORS AMONG SAUDIS

被引:21
作者
ALSHAMMARI, SA
ALI, M
ALSHAMMARI, A
ALMAATOUQ, M
TENNIER, A
ARMSTRONG, K
机构
[1] Primary Health Care Clinic, College of Medicine, King Saud University, Riyadh, 11461
关键词
D O I
10.1093/fampra/11.2.153
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A study of 1005 family practice attenders at King Fahad National Guard Hospital was conducted during February 1993 to determine the prevalence of hyperlipidaemia and its association with participants' sociodemographic characteristics and clinical problems. The percentage of patients with total serum cholesterol concentration (TSCC) of 5.2-6.8 mmol/l was 39.3%, while those with TSCC exceeding 6.8 mmol/l was 9.5%. Hypertriglyceridaemia (TG >2.5 mmol/l) was found in 5%. TSCC increased progressively with age up to the seventh decade. TSCC was higher among obese and diabetic patients than others. Obesity body mass index (BMI) >29.9 kg/m2 was found in 32.8%, diabetes mellitus in 24.2%, hypertension in 11.1% and both diabetes and hypertension in 6.4%. There is an urgent need to equip primary health care teams with training and resources to help them give proper dietary advice, modify the local lifestyle and screen at least high-risk groups for hyperlipidaemia and other coronary risk factors.
引用
收藏
页码:153 / 158
页数:6
相关论文
共 32 条
[1]  
Simons L.A., Interrelations of lipids and lipoproteins with, Am J Cardiol, 57, pp. I5G-I0G, (1986)
[2]  
Pyrola K., Interpopulation correlations between serum cholesterol level and the occurrence of coronary heart disease, Eur Heart J, 8, 2, pp. 23-30, (1987)
[3]  
Keys A., Menotti A., Aravanis C., The seven countries study
[4]  
2289 deaths in 15 years, Prev Med, 13, pp. 141-154, (1984)
[5]  
Martin M.J., Hulley S.B., Browner W.S., Serum cholesterol, blood pressure and mortality
[6]  
implications from cohort of 361662 men, Lancet, 2, pp. 933-936, (1986)
[7]  
Reaven R.G., Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension: Parallels between human disease and rodent models, Diabetic Care, 14, pp. 195-202, (1991)
[8]  
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, J am Medassoc, 251, pp. 365-374, (1984)
[9]  
Frick M.H., Elo O., Haapa K., Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease, N Engl J Med, 317, pp. 1237-1245, (1987)
[10]  
Inam S., Cumberbatch M., Judzewitsch R., Importance of cholesterol screening in Saudi Arabia, Saudi Med J, 12, pp. 215-220, (1991)